| Supriya Lifescience Ltd |
|---|
| Registered Office: 207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai - 400063, Maharashtra |
| Phone: 91-22-40332727 |
| Email: cs@supriyalifescience.com |
| Website: www.supriyalifescience.com |
| Initial public offering of 25,547,445* equity shares of face value of Rs. 2 each ("Equity Shares") of Supriya Lifescience Limited ("The Company" or the "Issuer") for cash at a price of Rs. 274 per equity share ("Offer Price") aggregating to Rs. 700.00 crores, comprising a fresh issue of 7,299,270* equity shares aggregating to Rs. 200.00 crores ("Fresh Issue") and an offer for sale of 18,248,175* equity shares aggregating to Rs. 500.00 crores by Satish Waman Wagh (The "Promoter Selling Shareholder") (The "Offer for Sale", together with the fresh issue, the "Offer"). The offer will constitute 31.74% of the post-offer paid-up equity share capital. *Subject to finalisation of basis of allotment The face value of each equity share is Rs. 2 each. The offer price is 137 times the face value of the equity shares. Bids can be made for a minimum of 54 equity shares and in multiples of 54 equity shares thereafter. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | Allotment |
| 16-Dec-2021 | 20-Dec-2021 | ₹ 274.00 | ₹ 0.00 |
| Minimum Application for shares in Nos : 54.0 Further Multiples of : 54.0 | ||
|---|---|---|
| (₹)Cr. | Lead Managers to the Issue | |
| Project Cost | 200.00 | Axis Capital Ltd |
| Project Financed through Current Offer | 700.00 | |
| Post Issue Equity Share Capital | 16.10 | |
| Issue Price | ₹274.00 | |
| Projects |
|---|
| Funding Capital Expenditure Requirements of the Company |
| Repayment and/or Pre-Payment, in full or part, of certain Borrowings availed by the Company |
| General Corporate Purposes |
| Promoted By |
|---|
| Satish Waman Wagh |
| Listing At |
|---|
| BSE |
| NSE |
| Registrar to the Issue |
|---|
